EIR Eli Lilly & Company May 2014

Myra Casey FDA, Andrea Swingle FDA$595.00 - Available Now

FDA investigators audited the Eli Lilly & Company - Indianapolis, IN, United States facility and issued inspectional observation (via FDA 483) on 08 May 2014.

Product details

  • Category:
  • Inspection end: 08 May 2014
  • Location: Indianapolis, United States
  • FEI: 1819470
Add To Cart